Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
H-FROG Feasibility Study
NCT07847710Phase 2Recruiting
- Sponsor
- Jiangsu Provincial People's Hospital
- Start
- Sep 2026
- Primary completion
- Mar 2028
- Countries
- 1
01
Overview
A Phase 2 trial of retlirafusp alfa in intrahepatic cholangiocarcinoma (ICC), sponsored by Jiangsu Provincial People's Hospital. Started Sep 2026; status: recruiting.
02
Drugs
retlirafusp alfa
03
Conditions
intrahepatic cholangiocarcinoma (ICC)
Beyond the preview
Go deeper on NCT07847710.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT07847710.